Synthesis and characterization of water-soluble hydroxybutenyl cyclomaltooligosaccharides (cyclodextrins)

被引:21
作者
Buchanan, CM
Alderson, SR
Cleven, CD
Dixon, DW
Ivanyi, R
Lambert, JL
Lowman, DW
Offerman, RJ
Szejtli, J
Szente, L
机构
[1] Eastman Chem Co, Res Labs, Kingsport, TN 37662 USA
[2] Cyclolab, H-1525 Budapest, Hungary
关键词
hydroxybutenyl cyclomaltooligosaccharide; hydroxybutenyl cyclodextrin; cyclodextrin ether; guest-host complex; glibenclamide; ibuprofen;
D O I
10.1016/S0008-6215(01)00328-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have examined the synthesis of hydroxybutenyl cyclomaltooligosaccharides (cyclodextrins) and the ability of these cyclodextrin ethers to form guest-host complexes with guest molecules. The hydroxybutenyl cyclodextrin ethers were prepared by a base-catalyzed reaction of 3,4-epoxy-1-butene with the parent cyclodextrins in an aqueous medium. Reaction byproducts were removed by nanofiltration before the hydroxybutenyl cyclodextrins were isolated by co-evaporation of water-EtOH. Hydroxy-butenyl cyclodextrins containing no unsubstituted parent cyclodextrin typically have a degree of substitution of 2-4 and a molar substitution of 4-7. These hydroxybutenyl cyclodextrins are randomly substituted, amorphous solids. The hydroxybutenyl cyclodextrin ethers were found to be highly water soluble. Complexes of HBen-beta-CD with glibenclamide and ibuprofen were prepared and isolated, In both cases, the guest content of the complexes was large, and a significant increase in the solubility of the free drug was observed. Dissolution of the complexes in pH 1.4 water was very rapid, and significant increases in the solubility of the free drugs were observed. Significantly, after reaching equilibrium concentration, a decrease in the drug concentration over time was not observed. (C) 2002 Eastman Chemical Company. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:493 / 507
页数:15
相关论文
共 11 条
[1]   The stability of cyclodextrin complexes in solution [J].
Connors, KA .
CHEMICAL REVIEWS, 1997, 97 (05) :1325-1357
[2]   THE SYNTHESIS OF FUNCTIONALIZED CYCLODEXTRINS AS SCAFFOLDS AND TEMPLATES FOR MOLECULAR DIVERSITY, CATALYSIS, AND INCLUSION PHENOMENA [J].
HANESSIAN, S ;
BENALIL, A ;
LAFERRIERE, C .
JOURNAL OF ORGANIC CHEMISTRY, 1995, 60 (15) :4786-4797
[3]   Polyanion inhibitors of HIV and other viruses. 7. Polyanionic compounds and polyzwitterionic compounds derived from cyclodextrins as inhibitors of HIV transmission [J].
Leydet, A ;
Moullet, C ;
Roque, JP ;
Witvrouw, M ;
Pannecouque, C ;
Andrei, G ;
Snoeck, R ;
Neyts, J ;
Schols, D ;
De Clercq, E .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (25) :4927-4932
[4]   DISTRIBUTION OF SUBSTITUENTS IN 2-HYDROXYPROPYL ETHERS OF CYCLOMALTOHEPTAOSE [J].
PITHA, J ;
RAO, CT ;
LINDBERG, B ;
SEFFERS, P .
CARBOHYDRATE RESEARCH, 1990, 200 :429-435
[5]   SUBSTITUTION IN BETA-CYCLODEXTRIN DIRECTED BY BASICITY - PREPARATION OF 2-O-[(R)-2-HYDROXYPROPYL], 6-O-[(R)-2-HYDROXYPROPYL], 2-O-[(S)-2-HYDROXYPROPYL] AND 6-O-[(S)-2-HYDROXYPROPYL] DERIVATIVES [J].
RAO, CT ;
LINDBERG, B ;
LINDBERG, J ;
PITHA, J .
JOURNAL OF ORGANIC CHEMISTRY, 1991, 56 (03) :1327-1329
[6]   Cyclodextrins: Their future in drug formulation and delivery [J].
Stella, VJ ;
Rajewski, RA .
PHARMACEUTICAL RESEARCH, 1997, 14 (05) :556-567
[7]   Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development [J].
Szente, L ;
Szejtli, J .
ADVANCED DRUG DELIVERY REVIEWS, 1999, 36 (01) :17-28
[8]   Direct preparation of cyclodextrin monophosphates [J].
Tarelli, E ;
Lemercinier, X ;
Wheeler, S .
CARBOHYDRATE RESEARCH, 1997, 302 (1-2) :27-34
[9]  
Thompson DO, 1997, CRIT REV THER DRUG, V14, P1
[10]   Cyclodextrin drug carrier systems [J].
Uekama, K ;
Hirayama, F ;
Irie, T .
CHEMICAL REVIEWS, 1998, 98 (05) :2045-2076